LPS-stimulated NF-κB p65 subunit nuclear translocation, visualized by immunofluorescence, was attenuated in both MS and T2DM subjects after MES + HS treatment (Figs. 3C and 4C). Here, NFKB1 is linked to myeloid sarcoma.